Status:
RECRUITING
Triage Survey for Infectious Disease Eligibility
Lead Sponsor:
Brooklyn Clinical Research
Conditions:
Vaccination; Infection
HIV-1-infection
Eligibility:
All Genders
18+ years
Brief Summary
SWIFT-ID-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials for diagnosis, treatment, or prevention of infectious...
Eligibility Criteria
Inclusion
- \- 1. Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed.
- 2\. Participant is at least 18 years old.
Exclusion
- Participants are pregnant, breast-feeding, or planning to become pregnant.
- History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results or makes them unsuitable for the study for another reason.
- Current or recent moderate or severe substance use disorder impacting their ability to follow study related procedures.
- Reported history of coagulopathy or bleeding disorder considered a contraindication to phlebotomy.
- Any condition that in the investigator's opinion makes a participant unsuitable for the clinical trial study.
- Currently employed by Swift Clinical Research Group, Inc. or any of its subsidiaries, including Brooklyn Clinical Research, or a first-degree relative of an employee.
Key Trial Info
Start Date :
June 28 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 28 2029
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06492187
Start Date
June 28 2024
End Date
January 28 2029
Last Update
July 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brooklyn Clinical Research
Brooklyn, New York, United States, 11226